Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2020-04-27 Legal Proceedings Report
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
Prijava transakcija rukovoditelja (Uredba o zlouporabi tržišta) 27.04.2020. oslobađanje zaloga.pdf
Legal Proceedings Report Classification · 99% confidence The document is titled "OBAVIJEST O TRANSAKCIJI DIONICAMA IZDAVATELJA MEDIKA D.D." (Notice of Transaction in Shares of Issuer MEDIKA D.D.) and explicitly references compliance with Article 19 of EU Regulation No 596/2014 (Market Abuse Regulation - MAR). It details the release of a lien (založno pravo) over 7,406 shares of the issuer by an entity (Auctor d.o.o.) whose management is closely linked to the issuer's board members (Ružica Vađić and Oleg Uskoković). This type of mandatory disclosure concerning transactions by persons discharging managerial responsibilities (PDMRs) or closely associated persons, specifically regarding shareholdings or encumbrances, falls under insider transaction reporting requirements. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate category for reporting personal share transactions or related events (like lien releases affecting control/ownership) by directors and executives, as defined by MAR Article 19 disclosures.
2020-04-27 Croatian
Najava sjednice Nadzornog odbora 30.04.2020..pdf
Report Publication Announcement Classification · 99% confidence The document is a short announcement from MEDIKA d.d. dated April 27, 2020, titled 'PREDMET – NAJAVA SJEDNICE NADZORNOG ODBORA' (SUBJECT – ANNOUNCEMENT OF THE SUPERVISORY BOARD MEETING). It explicitly states that a telephone meeting of the Supervisory Board will be held on April 30, 2020, to discuss the financial reports for the period 01.01.-31.03.2020 (Q1 2020). This document is not the financial report itself, but an announcement regarding an upcoming board meeting where financial results will be reviewed. Since it is an announcement about internal governance/board activity related to financial reporting, and it doesn't fit perfectly into ER (Earnings Release, which is usually the public release), CT (Call Transcript), or MDA (Management Discussion), it is best classified as a general Regulatory Filing (RNS) or potentially related to Governance (CGR) or Board/Management (MANG). Given the focus is on announcing the meeting agenda which includes reviewing financial reports, and it's a formal notice to the exchange (as indicated by referencing 'Pravila Burze' - Exchange Rules), RNS is the most appropriate general regulatory fallback for such specific procedural announcements that aren't standard disclosures like 10-K or ER.
2020-04-27 Croatian
Najava sjednice Uprave 29.04.2020..pdf
Report Publication Announcement Classification · 99% confidence The document is a short announcement (812 characters) from MEDIKA d.d. dated April 24, 2020. The subject line is 'PREDMET – NAJAVA SJEDNICE UPRAVE DRUŠTVA' (SUBJECT - ANNOUNCEMENT OF THE MANAGEMENT BOARD MEETING). The content explicitly states that a Management Board meeting will be held on April 29, 2020, to discuss the financial reports for the period 01.01.-31.03.2020. This is not the financial report itself, but an announcement regarding an upcoming internal meeting where financial results will be reviewed. Since there is no specific category for 'Announcement of Management Meeting', and it relates to the upcoming review of financial results (which would typically lead to an ER or IR), the most appropriate classification based on the provided definitions is a general Regulatory Filing (RNS), as it is a mandatory disclosure about an internal corporate event, or potentially a Report Publication Announcement (RPA) if the context implied the results themselves were being published, but here it is purely announcing the meeting agenda. Given the focus is on announcing a procedural event (the meeting) rather than publishing a report or result, RNS is the safest general regulatory disclosure category. However, since the core topic is the review of financial reports (Q1 2020), and it is a short notice, RNS is the best fit among the options, as RPA is usually reserved for announcing the publication of a specific report.
2020-04-27 Croatian
gfi-pod_Grupa Medika 31.12.2019.-tablice.xlsx
Financial Supplement Data
2020-03-27 Croatian
Medika Grupa 2019_revizorsko.pdf
Annual Report Classification · 100% confidence The document is a comprehensive 'Annual Report' (Godišnje izvješće) for Medika d.d. for the year ending December 31, 2019. It includes management reports, independent auditor's reports, consolidated financial statements (comprehensive income, financial position, cash flows), and notes to the financial statements. It is a full-length annual report, not an announcement or a summary. FY 2019
2020-03-27 Croatian
gfi-pod_Medika 31.12.2019.-tablice.xlsx
Financial Supplement Data
2020-03-27 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.